ARTICLE | Company News
KeyNeurotek, Max Planck Society deal
February 19, 2007 8:00 AM UTC
KeyNeurotek received exclusive rights to Max Planck’s method for identifying drug candidates that have an effect on FK506 binding proteins. The company also amended its collaboration with the society...